Datavault AI Announces Hockey Hall of Famer Jeremy Roenick Joins to Monetize Sports Data and Lead Pioneering International NIL Exchange

Datavault AI Announces Hockey Hall of Famer Jeremy Roenick Joins to Monetize Sports Data and Lead Pioneering International NIL Exchange Leave a reply Datavault AI’s International Name, Image and Likeness (“NIL”) Exchange will Solve for Regulatory Compliant with Quantum Encrypted Smart Contracts that will Present the Winning Solution PHILADELPHIA, Dec. 15, 2025 (GLOBE NEWSWIRE) — Datavault AI Inc. (NASDAQ: DVLT; the “Company” or “Datavault AI”), a leading provider of patented agentic AI platforms for data observation, valuation and monetization, today announced that former NHL player and Hockey Hall of Famer Jeremy Roenick is advising the Company to spearhead the development

Continue Reading ➜

Datavault AI Announces Hockey Hall of Famer Jeremy Roenick Joins to Monetize Sports Data and Lead Pioneering International NIL Exchange

Datavault AI Announces Hockey Hall of Famer Jeremy Roenick Joins to Monetize Sports Data and Lead Pioneering International NIL Exchange Leave a reply Datavault AI’s International Name, Image and Likeness (“NIL”) Exchange will Solve for Regulatory Compliant with Quantum Encrypted Smart Contracts that will Present the Winning Solution PHILADELPHIA, Dec. 15, 2025 (GLOBE NEWSWIRE) — Datavault AI Inc. (NASDAQ: DVLT; the “Company” or “Datavault AI”), a leading provider of patented agentic AI platforms for data observation, valuation and monetization, today announced that former NHL player and Hockey Hall of Famer Jeremy Roenick is advising the Company to spearhead the development

Continue Reading ➜

INSPIRE MEDICAL SYSTEMS DEADLINE: ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INSP

INSPIRE MEDICAL SYSTEMS DEADLINE: ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INSP Leave a reply NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Inspire Medical common stock during the Class Period you

Continue Reading ➜

INSPIRE MEDICAL SYSTEMS DEADLINE: ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INSP

INSPIRE MEDICAL SYSTEMS DEADLINE: ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INSP Leave a reply NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Inspire Medical common stock during the Class Period you

Continue Reading ➜

SYNOPSYS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Synopsys, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SNPS

SYNOPSYS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Synopsys, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SNPS Leave a reply NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the “Class Period”), of the important December 30, 2025 lead plaintiff deadline. SO WHAT: If you purchased Synopsys securities during the Class Period you may be entitled to compensation without payment of any out

Continue Reading ➜

SYNOPSYS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Synopsys, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SNPS

SYNOPSYS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Synopsys, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SNPS Leave a reply NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the “Class Period”), of the important December 30, 2025 lead plaintiff deadline. SO WHAT: If you purchased Synopsys securities during the Class Period you may be entitled to compensation without payment of any out

Continue Reading ➜

SYNOPSYS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Synopsys, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SNPS

SYNOPSYS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Synopsys, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SNPS Leave a reply NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the “Class Period”), of the important December 30, 2025 lead plaintiff deadline. SO WHAT: If you purchased Synopsys securities during the Class Period you may be entitled to compensation without payment of any out

Continue Reading ➜

DXCM DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 29 Deadline in Securities Class Action – DXCM

DXCM DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 29 Deadline in Securities Class Action – DXCM Leave a reply NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the “Class Period”) of the important December 29, 2025 lead plaintiff deadline. SO WHAT: If you purchased DexCom securities during the Class Period you may be entitled to compensation

Continue Reading ➜

Recent News